CEO Anne Wojcicki says she remains committed to taking 23andMe private and is “surprised and disappointed” after all seven independent board directors resigned
All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her …
Context & Ripple Effects
Wojcicki’s attempt to take 23andMe private followed a steep decline in the company’s valuation, as described in an April filing on her proposed take-private effort. The resignation of every independent director turns that proposal from a contested transaction into an acute board-governance problem.
The break comes after the board’s special committee had already declined to proceed with Wojcicki’s $0.40-per-share offer. That prior rejection makes the directors’ departure significant: the company has lost the independent body that was evaluating the CEO’s bid.
First-order effects
- 23andMe is left without independent directors just as its CEO says she will continue pursuing a buyout, disrupting normal independent oversight of that effort.
- Wojcicki’s proposed transaction loses its existing special-committee process after that committee had rejected her offer.
Second-order effects
- Shareholders and any prospective financing partners face greater uncertainty over how a revised take-private proposal would be evaluated and negotiated.
- 23andMe will need to rebuild independent board oversight before it can credibly run a renewed process for a CEO-led transaction.
Third-order effects
- If founder-led take-private attempts repeatedly collide with independent-board resistance, governance process becomes as decisive as price in determining whether distressed public companies can exit the market.
- The episode underscores a broader tension for companies built around valuable data assets: strategic ambitions can outlast public-market support, while independent directors remain the key check on who captures the remaining value.
The trend: This is one instance of weakened public companies testing founder-led paths back to private ownership, with independent-board oversight determining whether those paths are viable.